Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-416
Closed -$37.8K 387
2024
Q4
$37.8K Buy
+416
New +$38.2K ﹤0.01% 369
2021
Q2
Sell
-2,257
Closed -$597K 250
2021
Q1
$597K Buy
2,257
+87
+4% +$24.5K 0.16% 129
2020
Q4
$637K Buy
2,170
+970
+81% +$249K 0.19% 115
2020
Q3
$284K Sell
1,200
-1,626
-58% -$370K 0.12% 147
2020
Q2
$561K Buy
2,826
+1,307
+86% +$244K 0.26% 94
2020
Q1
$279K Sell
1,519
-1,864
-55% -$332K 0.2% 89
2019
Q4
$574K Buy
+3,383
New +$503K 0.34% 72

Other funds holding AMED

HBW Advisory Services's AMED Position: Q1 2025 in Review

HBW Advisory Services sold out of Amedisys (AMED) in Q1 2025, closing a stake of 416 shares — an estimated $37.8K sold.

HBW Advisory Services first reported a position in AMED in Q4 2019 and held it in 7 quarters. The position peaked at $637K in Q4 2020. 305 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • HBW Advisory Services reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • HBW Advisory Services sold 416 Amedisys shares in Q1 2025, an estimated $37.8K.
  • HBW Advisory Services first reported a position in Amedisys in Q4 2019 and held it in 7 quarters.
  • HBW Advisory Services's Amedisys position peaked at $637K in Q4 2020.
  • 305 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on HBW Advisory Services's 13F filing for Q1 2025, filed 9 Apr 2025.